Group B Streptococcus is a round bacterium that grows in short chains and stains purple under the standard laboratory technique called a Gram stain. Its full scientific name is Streptococcus agalactiae, and it is one of several streptococcal species that live as part of the normal flora of the human body. In women, GBS naturally colonises the vagina, the rectum, the perineum and sometimes the urinary tract, much in the same way that a different set of bacteria live harmlessly on the skin or in the mouth. Carrying GBS does not mean infection, does not mean illness, and does not produce any symptoms — most women who carry it have no idea unless a swab is done and cultured.

Indian prevalence studies put the carrier rate at somewhere between twelve and fifteen percent of pregnant women, with some regional series higher or lower. That sits at the lower end of the global range, which runs from around ten percent in some Asian populations to thirty percent or more in some Western series. The rate also varies between women, between pregnancies in the same woman, and even between visits during the same pregnancy, which is part of why GBS is screened so close to the expected delivery date in countries where universal screening is offered.

GBS is emphatically not a sexually transmitted infection and the colonisation has nothing to do with hygiene, cleanliness, lifestyle, diet or anything else the woman might be doing differently. Carrying it does not mean a previous infection, does not mean a current one, and does not need to be treated outside of pregnancy. The reason it matters in pregnancy is the brief window during birth when the baby passes through a birth canal where the bacterium is present, and a vulnerable newborn immune system meets a bacterium that would not bother an adult.

The clinical concern with GBS in pregnancy is a condition called early-onset GBS disease in the newborn, which by definition occurs in the first seven days of life and most often in the first twenty-four to forty-eight hours after birth. The bacterium reaches the baby during the actual passage through the birth canal in a vaginal delivery, colonises the baby's skin, respiratory tract or gut, and in a small proportion of cases invades into the bloodstream. From there it can cause sepsis, pneumonia or meningitis, and at the most severe end of the spectrum it can be fatal or leave long-term neurological injury such as hearing loss, developmental delay or seizures.

Without any intervention, the rate of early-onset GBS disease is around one to two cases per thousand live births in carrier-mother populations. With intravenous antibiotics given to the mother in labour, that rate falls to roughly five cases per ten thousand births, a reduction of about ninety to ninety-five percent. The number-needed-to-treat is therefore large in absolute terms — many women receive the antibiotic for every newborn infection prevented — but the prevention is real and the alternative is a serious illness in a newborn at a moment when nothing else is going on yet.

Late-onset GBS disease, which occurs between seven days and three months of age, also exists but is not prevented by antibiotics in labour. It is much less common and the mechanisms are different; the conversation in this article is about the early-onset window, which is what intrapartum antibiotic prophylaxis is designed to prevent. For the wider context of how the labour and delivery is planned, What Is a Birth Plan? Your Complete India-Ready Guide is the right framework for slotting in a question about GBS prophylaxis alongside the other choices.

In the United States the Centers for Disease Control and Prevention have recommended universal GBS screening of every pregnant woman since the early 2000s, with a vaginal-rectal swab taken at thirty-five to thirty-seven weeks of gestation and cultured for GBS. The same approach is followed in most of Europe and in the United Kingdom, where the practice is now standard antenatal care. Women whose culture comes back positive are flagged in their notes, and the moment they go into labour, intravenous antibiotics are started.

India does not yet have universal GBS screening as part of routine antenatal care. Government hospitals across most states do not offer the swab at all, and even where the lab capacity exists, the cost and logistics of swabbing every pregnant woman at thirty-five to thirty-seven weeks have prevented adoption at scale. In private hospitals the swab is technically available — most large lab chains and corporate hospital labs run a GBS culture for roughly five hundred to two thousand rupees on request — but it is not done by default. Many women only learn that the test exists when they ask, and many obstetricians will only request it if the woman raises it first or if there is a specific risk factor that prompts the conversation.

The official Indian protocol that fills this gap is the Federation of Obstetric and Gynaecological Societies of India guideline, most recently updated in 2017, which recommends a risk-factor-based approach rather than universal screening. Under this approach, every woman in labour is assessed for a defined set of risk factors, and intravenous antibiotic prophylaxis is given to anyone who has at least one of them, regardless of whether a GBS swab has been done. It is an imperfect approach — risk-based prophylaxis catches fewer GBS-positive women than universal screening — but it works at the scale of the Indian public health system and does prevent a meaningful share of early-onset newborn infections.

• A previous baby with proven GBS infection — once a woman has had one newborn with GBS sepsis, pneumonia or meningitis, all her future deliveries automatically qualify for intrapartum antibiotic prophylaxis, regardless of culture status in subsequent pregnancies.
• GBS bacteriuria in the current pregnancy — if a urine culture done at any point in the current pregnancy grew GBS at a significant count, the carrier status is considered confirmed and antibiotics in labour are indicated, because heavy colonisation makes vertical transmission more likely.
• Preterm labour before thirty-seven completed weeks — preterm babies are much more vulnerable to GBS infection because their immune system is less mature and the protective antibody transfer from mother across the placenta is incomplete, so antibiotic prophylaxis is given without waiting for a culture.
• Ruptured membranes for more than eighteen hours before delivery — once the protective amniotic barrier has been broken for longer than eighteen hours, the rate of ascending infection rises sharply and antibiotic prophylaxis is started even without a known GBS result.
• Maternal fever in labour above thirty-eight degrees Celsius — a temperature above thirty-eight in labour may signal chorioamnionitis, an infection of the membranes and amniotic fluid, and broad-spectrum antibiotics that cover GBS are started promptly.

The first-line drug for intrapartum GBS prophylaxis is intravenous penicillin G, given as a loading dose at the start of labour and then repeated every four hours until delivery. The first alternative when penicillin is in short supply is intravenous ampicillin, which works against GBS in much the same way. For women with a confirmed penicillin allergy, the antibiotic of choice depends on how serious the reaction has been and on whether the local GBS isolate is sensitive — clindamycin is commonly used when sensitivity is known, and vancomycin is held in reserve for severe allergy or resistant isolates.

The single most important practical fact about the antibiotic is timing. For full protection, the mother needs to receive at least two doses at least four hours apart before the baby is delivered. That is why the antibiotic is started as soon as active labour is established or as soon as the membranes rupture, whichever comes first, and not held back until delivery is imminent. A woman who arrives in advanced labour and delivers within an hour of admission cannot get full prophylaxis simply because there is not enough time, which is one of the reasons obstetric teams take labour onset and waters breaking seriously.

Intrapartum antibiotic prophylaxis is not perfect even when it is given on time. The rate of breakthrough early-onset GBS disease in babies whose mothers received adequate intravenous penicillin is somewhere around five to ten percent of what it would have been without treatment, but it is not zero. That is why the newborn is still observed carefully for the first forty-eight to seventy-two hours after a GBS-exposed delivery, and why the warning signs covered later in this article matter even when the antibiotic was given as planned.

If a caesarean section is performed before labour starts and before the membranes have ruptured, the baby does not pass through the birth canal and the risk of GBS transmission is much lower. In that specific situation — a planned caesarean with intact membranes and no labour — current guidelines do not recommend GBS prophylaxis even when the mother is known to be a carrier. The pre-operative antibiotic that is given as standard surgical prophylaxis is a different drug, given for a different reason, and is not a substitute for GBS prophylaxis in labour.

If a woman who was scheduled for a caesarean goes into labour first, or if her membranes rupture before the scheduled time, the picture changes. Once labour is established or the waters have broken, the same risk-factor-based or culture-based decision applies, and intrapartum antibiotic prophylaxis is started in the usual way. The pre-operative surgical antibiotic at the start of the caesarean is then given on top, with appropriate adjustment so the same drug is not double-dosed.

If a caesarean is unplanned and happens after labour has been going on for hours, the prophylaxis question is the same as for a vaginal delivery — the antibiotic decision is driven by labour onset, by ruptured membranes and by risk factors, not by the eventual route of delivery. The conversation with the obstetrician is worth having ahead of time so the plan does not need to be assembled in the labour room.

• Fever above thirty-eight degrees Celsius, or unusually low temperature below thirty-six, in a newborn during the first week of life — both can be early signs of serious infection and need same-day medical assessment.
• Unusual lethargy or being hard to wake for feeds — a healthy newborn wakes for feeds every two to three hours, and a baby who is sleeping through feeds or hard to rouse needs urgent review.
• Poor feeding or refusal of the breast or bottle, especially when combined with any other warning sign on this list.
• Fast breathing above sixty breaths a minute, grunting with each breath, flaring of the nostrils, or visible pulling-in of the chest wall between the ribs.
• A baby that is floppy and limp when picked up, or conversely unusually stiff or arching backward, or that has a seizure or twitching movements.
• Any blueish or unusually pale colour around the lips, the face or the fingertips, especially if accompanied by fast breathing or poor feeding — call the emergency ambulance one zero eight or the maternal-child health line one zero two and go to a hospital immediately, do not wait for the next outpatient appointment.

• Did you check my GBS status with a vaginal and rectal swab, and if not, can we arrange the test now at thirty-five to thirty-seven weeks?
• If I am positive, will I receive intravenous penicillin in labour, and roughly how many doses are needed before delivery for full protection?
• If no swab is done and you are following the risk-based protocol, which of the five risk factors would trigger antibiotic prophylaxis for me?
• I have a penicillin allergy — what is the backup antibiotic plan and is sensitivity testing done on the local GBS isolates?
• If I am booked for a planned caesarean, what happens if I go into labour first or if my waters break before the scheduled date?
• What is the hospital's policy on newborn observation in the first forty-eight to seventy-two hours after a GBS-exposed birth, and what discharge advice will I get about warning signs?
• Approximately how much does the GBS swab cost here, and is it included in my antenatal package or billed separately?

GBS in pregnancy is a small but real problem with a well-defined solution. The bacterium itself is harmless to the mother and lives quietly in about one in seven to one in three pregnant women across India. The risk only matters at the moment of birth, and intravenous antibiotics given to the mother in labour cut that risk by roughly nineteen out of twenty. The catch is that India does not yet do universal screening, so the swab is either requested by the woman in a private hospital or skipped entirely in favour of a risk-factor-based protocol drawn from the Federation of Obstetric and Gynaecological Societies of India 2017 guideline.

Practically, that means the conversation has to be started by the woman. Ask your obstetrician at thirty-five to thirty-seven weeks whether the GBS swab can be done; if the answer is no or unaffordable, ask which of the five risk factors would trigger antibiotic prophylaxis in your labour anyway. Brief whoever will be with you in the labour room so the question can be raised again if you are not in a state to negotiate calmly. Know the early-warning signs in the newborn for the first week after discharge so an early infection is caught and treated quickly. For the wider conversation about how to advocate for yourself and to build the people around you who will help you do it, Building Your Village: Partner, Mother‑in‑Law & Community Health Worker sets the foundation that the labour-room request rests on.

If you ever feel that a reasonable question about GBS, the swab or the antibiotic in labour is being brushed off — particularly in a setting where you suspect cost or convenience is driving the answer more than evidence — the wider pattern in When Doctors Don’t Listen: Advocating for Your Health is worth reading for context, and a second opinion is always reasonable. The antenatal visit framework in What to Expect Week by Week During Pregnancy puts the thirty-five to thirty-seven week conversation in its proper place in the timeline, so the question is not raised for the first time in the labour room.